Literature DB >> 27450721

Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells.

Athanasia Pavlopoulou1, Yavuz Oktay2, Konstantinos Vougas3, Maria Louka4, Constantinos E Vorgias4, Alexandros G Georgakilas5.   

Abstract

Breast cancer cells are suggested to be organized in a hierarchical manner with a subpopulation of stem cells, termed as breast cancer stem cells (BCSCs), which contribute significantly to tumorigenesis, cancer recurrence and metastasis. BCSCs have been demonstrated to exhibit significant resistance to conventional chemo- and radiotherapy. Recent evidence suggests that treatment of breast cancers with radiation or chemotherapy agents induces stem cell-like properties in non-stem cells. Herein, we provide an overview of the key determinants of resistance to chemotherapy and radiation in BCSCs. To this end and by the use of bioinformatics, the molecular pathways, the defining markers, as well as the microenvironmental and genetic factors, which are implicated in the maintenance of stemness, chemo- and radioresistance in BCSCs, are identified and presented. Our findings could provide the foundation for the design of targeted chemo- or radiotherapeutic regimens in order to eliminate or sensitize BCSCs to cytotoxic therapies and prevent tumor relapse and metastasis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bioinformatics; Breast cancer stem cells; Chemoresistance; Chemotherapy; Radioresistance; Radiotherapy

Mesh:

Substances:

Year:  2016        PMID: 27450721     DOI: 10.1016/j.canlet.2016.07.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer.

Authors:  Le Zhang; Milana Bochkur Dratver; Taha Yazal; Kevin Dong; Andrea Nguyen; Garrett Yu; Amy Dao; Michael Bochkur Dratver; Sara Duhachek-Muggy; Kruttika Bhat; Claudia Alli; Frank Pajonk; Erina Vlashi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-09-07       Impact factor: 7.038

Review 2.  The challenge of drug resistance in cancer treatment: a current overview.

Authors:  Michail Nikolaou; Athanasia Pavlopoulou; Alexandros G Georgakilas; Efthymios Kyrodimos
Journal:  Clin Exp Metastasis       Date:  2018-05-24       Impact factor: 5.150

3.  An innovative systematic approach introduced the involved lncRNA-miR-mRNA network in cell cycle and proliferation after conventional treatments in breast cancer patients.

Authors:  Maryam Mohsenikia; Solmaz Khalighfard; Ali Mohammad Alizadeh; Vahid Khori; Maziar Ghandian Zanjan; Mohammadreza Zare; Ramesh Omranipour; Elham Patrad; Hengamesadat Razavi; Ziba Veisi Malekshahi; Zahra Bagheri-Hosseinabadi
Journal:  Cell Cycle       Date:  2022-05-15       Impact factor: 5.173

4.  Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity.

Authors:  Pavel Lobachevsky; Trevor Leong; Patricia Daly; Jai Smith; Nickala Best; Jonathan Tomaszewski; Ella R Thompson; Na Li; Ian G Campbell; Roger F Martin; Olga A Martin
Journal:  Cancer Lett       Date:  2016-09-28       Impact factor: 8.679

5.  Nrf2 inhibition sensitizes breast cancer stem cells to ionizing radiation via suppressing DNA repair.

Authors:  Shenghui Qin; Xiaoyuan He; Houmin Lin; Bradley A Schulte; Mingfeng Zhao; Kenneth D Tew; Gavin Y Wang
Journal:  Free Radic Biol Med       Date:  2021-04-20       Impact factor: 8.101

6.  Prediction of Gold Nanoparticle and Microwave-Induced Hyperthermia Effects on Tumor Control via a Simulation Approach.

Authors:  Nikolaos M Dimitriou; Athanasia Pavlopoulou; Ioanna Tremi; Vassilis Kouloulias; Georgios Tsigaridas; Alexandros G Georgakilas
Journal:  Nanomaterials (Basel)       Date:  2019-01-29       Impact factor: 5.076

7.  Effects of Shen Cao Granules on Chemotherapy-Induced Thrombocytopenia in Gastrointestinal Cancer Patients: A Randomized Controlled Trial.

Authors:  Chunfeng Yu; Wei Liu; Yuejun Mu; Aihua Hou; Yin Li
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

8.  RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.

Authors:  Annapurna Pranatharthi; Pavana Thomas; Avinash H Udayashankar; Chandra Bhavani; Srinag Bangalore Suresh; Sudhir Krishna; Jayashree Thatte; Nirmala Srikantia; Cecil R Ross; Sweta Srivastava
Journal:  J Exp Clin Cancer Res       Date:  2019-09-05

Review 9.  Potential Role of MSC/Cancer Cell Fusion and EMT for Breast Cancer Stem Cell Formation.

Authors:  Ralf Hass; Juliane von der Ohe; Hendrik Ungefroren
Journal:  Cancers (Basel)       Date:  2019-09-25       Impact factor: 6.639

Review 10.  The Regulatory Role of MicroRNAs in Breast Cancer.

Authors:  Hui-Yi Loh; Brendan P Norman; Kok-Song Lai; Nik Mohd Afizan Nik Abd Rahman; Noorjahan Banu Mohamed Alitheen; Mohd Azuraidi Osman
Journal:  Int J Mol Sci       Date:  2019-10-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.